Flat ₹100 OFF on First app order | Use Code: APP100 |
Flat ₹100 OFF
on First app order
Use Code
APP100
Download Now
Salt CompositionLopinavir 133.3mg + Ritonavir 33.3mg
V Letra 33.3 mg/133.3 mg Capsule
You Searched
V Letra 33.3 mg/133.3 mg Capsule
Sun Pharmaceutical Industries Ltd.
₹2,900
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Customers also bought
More About V Letra
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How it works
V Letra 33.3 mg/133.3 mg Capsule is an anti-HIV medication. It works by interfering with an enzyme (protease), which is required by HIV-infected cells to make new viruses. This stops the production of new viruses.
Caution: It is important to consult your doctor regarding alcohol consumption while taking V Letra 33.3 mg/133.3 mg Capsule .
Seek medical advice from your doctor: V Letra 33.3 mg/133.3 mg Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Safe when prescribed by an expert: V Letra 33.3 mg/133.3 mg Capsule is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Seek medical advice from your doctor: It is not known whether V Letra 33.3 mg/133.3 mg Capsule alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Safe when prescribed by an expert: V Letra 33.3 mg/133.3 mg Capsule is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of V Letra 33.3 mg/133.3 mg Capsule may not be needed in these patients. Doctor consultation is advised.
Caution Advised: V Letra 33.3 mg/133.3 mg Capsule should be used with caution in patients with liver disease. Dose adjustment of V Letra 33.3 mg/133.3 mg Capsule may be needed. Doctor consultation is advised.
What if I forget to take it?
If a dose of V Letra 33.3 mg/133.3 mg Capsule is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
Plot no 107/108,Namli block , Ranipool, East Sikkim 737135
References
Ciplamed. Ritonavir+Lopinavir (on 10 Apr. 2019 )
Ritonavir+Lopinavir. North Chicago, Illinois: Abbott Laboratories; 2010 (10 Apr. 2019)
Ritonavir/Lopinavir. Maidenhead, Berkshire: AbbVie Ltd.; 2001 (10 Apr. 2019)
Ritonavir+Lopinavir. Barceloneta, Puerto Rico: AbbVie Ltd.; 2000 (10 Apr. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.